Livzon Pharmaceutical Group, Inc. (LVZPF)
3.799
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.373B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 16.87% |
| Valuation | |
| PE Ratio | 14.04 |
| PE Ratio (Forward) | |
| PS Ratio | 2.194 |
| Price to Book Value | 1.712 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.2097 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.317 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 27.56% |
Profile
| Livzon Pharmaceutical Group, Inc. engages in the research and development, production, and distribution of pharmaceutical products. It offers drug preparation products, bulk medicines and intermediates, and diagnostic reagents and equipment. The company was founded on March 1, 1992, and is headquartered in Zhuhai, China. |
| URL | http://www.livzon.com.cn |
| Investor Relations URL | N/A |
| HQ State/Province | Guangdong |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Oct. 22, 2026 (est.) |
| Last Earnings Release | Aug. 21, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 17, 2026 |
Profile
| Livzon Pharmaceutical Group, Inc. engages in the research and development, production, and distribution of pharmaceutical products. It offers drug preparation products, bulk medicines and intermediates, and diagnostic reagents and equipment. The company was founded on March 1, 1992, and is headquartered in Zhuhai, China. |
| URL | http://www.livzon.com.cn |
| Investor Relations URL | N/A |
| HQ State/Province | Guangdong |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Oct. 22, 2026 (est.) |
| Last Earnings Release | Aug. 21, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 17, 2026 |